Not Yet Recruiting NA INTERVENTIONAL 1-arm
NCT06825663
Marker of Brain Insulin Resistance in AD Prognosis (IREN)
Brain Insulin Resistance Index in Plasma Neuronal Exosomes As Predictive Biomarkers of Alzheimer's Disease
Sponsor: Central Hospital, Nancy, France
Interventions
Blood punction
Updated 1 time since 2025 Last updated: Feb 10, 2025 Started: Mar 15, 2025 Primary completion: Sep 1, 2027 Completion: Sep 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Brain Insuline Resistance and Mild Cognitive Impairment and is currently actively recruiting participants. Central Hospital, Nancy, France leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Central Hospital, Nancy, France
- Laure Joly
- Thérèse Jonveaux
Data source: Central Hospital, Nancy, France
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.